Analyst Ratings for Clearside Biomedical (CLSD)
CLSD Rating Summary
CLSD Price Target Summary
- Highest: $8.00 (Stifel)
- Lowest: $4.00 (Needham & Company)
- Average: $6.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.00 (+545.2%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 75%
Avg. $ Target:
$6.00 (+545.2%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/10/2022 | Needham & Company » Updated 3/10/2023 |
Serge Belanger | Upgrade | Buy (Hold) |
4.00 (5.00) |
1.28 (0.93) |
-27.34% | Details |
| 11/9/2022 | Stifel | Annabel Samimy | Upgrade | Buy (Hold) |
8.00 (N/A) |
1.40 (0.93) |
-33.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
